Filing Details
- Accession Number:
- 0001209191-16-106791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-07 20:44:08
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-07
- Accepted Time:
- 2016-03-07 20:44:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1654482 | Mohammad Hirmand | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Interim Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-03-04 | 1,525 | $41.10 | 39,342 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- The shares were sold at prices between $41.0981 and $41.115. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes 454 shares purchased through the issuer's ESPP.